TY - JOUR
KW - 3291:Immunological Disorders
KW - 3363:Medical Treatment of Physical Illness
KW - Addiction Severity Index
KW - Adulthood (18 yrs & older)
KW - antiretroviral therapy
KW - article
KW - buprenorphine
KW - Clinical Epidemiological Scale for Depression
KW - Drug Dependency
KW - Drug Therapy
KW - drug treatment
KW - Empirical Study
KW - Female
KW - HIV treatment outcome
KW - Human
KW - Longitudinal Study
KW - Male
KW - Medical Outcomes Study Short Form Health Survey
KW - naloxone
KW - Opiates
KW - opioid dependent patients
KW - Quantitative Study
KW - Treatment Outcome/Clinical Trial
KW - Treatment Outcomes
KW - US
AU - Frederick L. Altice
AU - Douglas Bruce
AU - Gregory M. Lucas
AU - Paula J. Lum
AU - Todd Korthuis
AU - Timothy P. Flanigan
AU - Chinazo O. Cunningham
AU - Lynn E. Sullivan
AU - Pamela Vergara-Rodriguez
AU - David A. Fiellin
AU - Adan Cajina
AU - Michael Botsko
AU - Vijay Nandi
AU - Marc N. Gourevitch
AU - Ruth Finkelstein
A1 - 
BT - JAIDS Journal of Acquired Immune Deficiency Syndromes
C5 - Opioids & Substance Use
CP - Suppl 1
IS - Suppl 1
JF - JAIDS Journal of Acquired Immune Deficiency Syndromes
PB - Lippincott Williams & Wilkins
PY - 2011
SN - 1525-4135, 1525-4135
SP - S22
EP - S32
EP - 
T1 - HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study.
T2 - JAIDS Journal of Acquired Immune Deficiency Syndromes
TI - HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study.
U1 - Opioids & Substance Use
UR - http://search.proquest.com/docview/888750374?accountid=28100
VL - 56
VO - 1525-4135, 1525-4135
Y1 - 2011
ER -